Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza

Equine Veterinary Journal

Volumn 45, Issue 2, 2013, Pages 235-239

  El Hage, C M ^a   Savage, C J ^b,e   Minke, J M ^c   Ficorilli, N P ^a   Watson, J ^d   Gilkerson, J R ^a  

^a The University of Melbourne   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d CSIRO   (Australia)

^e Southpaws   (Australia)

Author keywords

Accelerated schedule; ALVAC; Equine influenza; Horse; Recombinant canarypox vectored virus; Vaccination

Indexed keywords

EQUIDAE;

EID: 84873130753     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/j.2042-3306.2012.00605.x     Document Type: Article

References (46)

1. Landolt, G.A., Townsend, H.G. and Lunn, D.P. (2007) Equine influenza. In: Equine Infectious Diseases, Eds: D. Sellon and M. Long, Elsevier, St Louis. pp 124-134.
2. Hannant, D. and Mumford, J. (1996) Virus infections of equines. In: Virus Infections of Equines, Ed: M. Studdert, Elsevier, Amsterdam. pp 285-293.
3. Paillot, R., Hannant, D., Kydd, J.H. and Daly, J.M. (2006) Vaccination against equine influenza: quid novi? Vaccine 24, 4047-4061.
4. van Maanen, C. and Cullinane, A. (2002) Equine influenza virus infections: an update. Vet. Q. 24, 79-94.
5. Callinan, I. (2008) Equine Influenza: The August 2007 Outbreak in Australia, Commonwealth of Australia, Canberra. http://www.equineinfluenzainquiry.gov.au. Last accessed 17/03/2012.
6. Garner, M.G., Cowled, B., East, I.J., Moloney, B.J. and Kung, N.Y. (2010) Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza-A modelling approach. Prev. Vet. Med. 99, 15-27.
7. Epidemiology Support Group (2009) Equine Influenza 2007 The Australian experience Report from the EI Epidemiology Support Group to the Consultative Committee on Emergency Animal Disease December 2008. pp 62-74.
8. Guthrie, A.J. (2006) Equine influenza in South Africa 2003 Outbreak. In: Proceedings of the 9th International Congress of World Equine Veterinary Association, Marrakech, Morocco.
9. Mumford, J.A. and Wood, J. (1992) Establishing an acceptability threshold for equine influenza vaccines. Dev. Biol. Stand. 79, 137-146.
10. Morley, P.S., Townsend, H.G., Bogdan, J.R. and Haines, D.M. (1999) Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J. Am. Vet. Med. Ass. 215, 61-66.
11. Newton, J.R. (2001) Equine influenza vaccine performance: still learning lessons from the field. Vet. J. 161, 107-109.
12. Mumford, J.A., Jessett, D.M., Rollinson, E.A., Hannant, D. and Draper, M.E. (1994) Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet. Rec. 134, 158-162.
13. Hannant, D., Mumford, J.A. and Jessett, D.M. (1988) Duration of circulating antibody and immunity following infection with equine influenza virus. Vet. Rec. 122, 125-128.
14. Bryant, N.A., Rash, A.S., Woodward, A.L., Medcalf, E., Helwegen, M., Wohlfender, F., Cruz, F., Herrmann, C., Borchers, K., Tiwari, A., Chambers, T.M., Newton, J.R., Mumford, J.A. and Elton, D.M. (2011) Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet. Microbiol. 147, 19-27.
15. Nelson, K., Schram, B.R., McGregor, M.W., Sheoran, A.S., Olsen, C.W. and Lunn, D.P. (1998) Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 16, 1306-1313.
16. Anon (2008) Animal Health Surveillance Quarterly (AHSQ), pp 2-3.
17. Arthur, R.J. and Suann, C.J. (2011) Biosecurity and vaccination strategies to minimise the effect of an equine influenza outbreak on racing and breeding. Aust. Vet. J. 89, Suppl 1, 109-113.
18. Edlund Toulemonde, C., Daly, J., Sindle, T., Guigal, P.M., Audonnet, J.C. and Minke, J.M. (2005) Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet. Rec. 156, 367-371.
19. Kirkland, P. and Delbridge, G. (2011) Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies. Aust. Vet. J. 89, Suppl 1, 45-46.
20. Minke, J.M., Audonnet, J.-C. and Fischer, L. (2004) Equine viral vaccines: the past, present and future. Vet. Res. 35, 425-443.
21. Gildea, S., Arkins, S., Walsh, C. and Cullinane, A. (2011) A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt Horses - a randomised blind study. Vaccine 29, 3917-3922.
22. Gildea, S., Arkins, S., Walsh, C. and Cullinane, A. (2011) A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings - a randomised blind study. Vaccine 29, 9214-9223.
23. Minke, J.M., Toulemonde, C.E., Dinic, S., Cozette, V., Cullinane, A. and Audonnet, J.C. (2007) Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine. J. Comp. Pathol. 137, Suppl 1, S76-S80.
24. Newton, J.R., Townsend, H.G., Wood, J.L., Sinclair, R., Hannant, D. and Mumford, J.A. (2000) Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet. J. 32, 65-74.
25. Kirkland, P. and Jeggo, M. (2008) The diagnosis and characterisation of equine influenza in Australia in 2007. Aust. Equine Vet. 27, 444-446.
26. Jeggo, M.H., Hammond, J.M. and Kirkland, P.D. (2008) The initial diagnosis of equine influenza in Australia in 2007. Microbiol. Aust. 29, 80-82.
27. Sergeant, E.S., Kirkland, P.D. and Cowled, B.D. (2009) Field evaluation of an equine influenza ELISA used in New South Wales during the 2007 Australian outbreak response. Prev. Vet. Med. 92, 382-385.
28. Minke, J.M., Toulemonde, C.E., Coupier, H., Guigal, P.M., Dinic, S., Sindle, T., Jessett, D., Black, L., Bublot, M., Pardo, M.C. and Audonnet, J.C. (2007) Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am. J. Vet. Res. 68, 213-219.
29. Mumford, J.A., Wood, J.M., Scott, A.M., Folkers, C. and Schild, G.C. (1983) Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J. Hyg. (Lond.) 90, 385-395.
30. Wood, J.M., Mumford, J., Folkers, C., Scott, A.M. and Schild, G.C. (1983) Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. J. Hyg. (Lond.) 90, 371-384.
31. Mumford, J.A., Wilson, H., Hannant, D. and Jessett, D.M. (1994) Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol. Infect. 112, 421-437.
32. Cullinane, A., Weld, J., Osborne, M., Nelly, M., McBride, C. and Walsh, C. (2001) Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet. J. 161, 174-185.
33. Heldens, J.G.M., van Loon, A.A.W.M. and van de Zande, S. (2007) Is there a benefit from an early booster vaccination in the control of equine influenza? Vet. J. 174, 592-598.
34. Newton, J.R., Lakhani, K.H., Wood, J.L. and Baker, D.J. (2000) Risk factors for equine influenza serum antibody titres in young Thoroughbred racehorses given an inactivated vaccine. Prev. Vet. Med. 46, 129-141.
35. Petermann, H.G., Stellmann, C. and Graveline, P. (1972) A study of different equine influenza vaccination schedules in seronegative foals and in horses. Zentralbl. Veterinärmed. B 20, 361-366.
36. Fine, P.E. (1993) Herd immunity epidemiol. Review 15, 265-302.
37. Mumford, J.A. and Wood, J. (1993) WHO/OIE meeting: consultation on newly emerging strains of equine influenza. Vaccine 11, 1172-1174.
38. Mumford, J.A. (1992) Progress in the control of equine influenza. In: Equine Infectious Diseases VI, Eds: W. Plowright, P.D. Rossdale and J.F. Wade, R & W Publications, Newmarket. pp 207-217.
39. Kannegieter, N., Frogley, A., Crispe, E. and Kirkland, P.D. (2011) Clinical outcomes and virology of equine influenza in a naive population and in horses infected soon after receiving one dose of vaccine. Aust. Vet. J. 89, Suppl 1, 139-142.
40. Perkins, N.R., Webster, W.R., Wright, T., Denney, I. and Links, I. (2011) Vaccination program in the response to the 2007 equine influenza outbreak in Australia. Aust. Vet. J. 89, Suppl 1, 126-134.
41. Newton, J.R., Daly, J.M., Spencer, L. andMumford, J.A. (2006) Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet. Rec. 158, 185-192.
42. Yates, P. and Mumford, J.A. (2000) Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 74, 173-177.
43. Lunn, D.P. (2000) Immunological basis of vaccination. Proc. Am. Ass. Equine Practnrs. 46, 1-9.
44. Paillot, R., Kydd, J.H., Sindle, T., Hannant, D., Edlund Toulemonde, C., Audonnet, J.C., Minke, J.M. and Daly, J.M. (2006) Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet. Immunol. Immunopathol. 112, 225-233.
45. Paillot, R. and Prowse, L. (2012) ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse. Vet. Immunol. Immunopathol. 145, 516-521.
46. Newton, J.R., Texier, M.J. and Shepherd, M. (2005) Modifying likely protection from equine influenza vaccination by varying dosage intervals within the Jockey Club Rules of Racing. Equine Vet. Educ. 17, 314-318.